Analysts See 12% Upside For The Holdings of VIOV

The Vanguard S&P Small-Cap 600 Value ETF (VIOV) has an implied analyst target price of $105.50, indicating an 11.80% upside from its recent $94.37 trading price, derived from the weighted average of its underlying holdings' analyst targets. This potential is significantly influenced by key components such as Minerals Technologies (MTX), Sun Country Airlines (SNCY), and Edgewell Personal Care (EPC), which analysts project to have substantial individual upsides of 30.10%, 26.28%, and 19.98% respectively. This analysis highlights a notable analyst consensus regarding the growth prospects within VIOV's small-cap value portfolio.

Analysis

The Vanguard S&P Small-Cap 600 Value ETF (VIOV) exhibits a potential 11.80% upside, based on a weighted average of analyst price targets for its underlying holdings, implying a target of $105.50 per unit against a recent price of $94.37. This aggregated analyst outlook suggests a perceived undervaluation within the small-cap value segment. The potential return is significantly influenced by key constituents with substantial projected individual growth, including Minerals Technologies (MTX) with a 30.10% upside to its $82.00 target, Sun Country Airlines (SNCY) with a 26.28% upside to its $16.55 target, and Edgewell Personal Care (EPC) with a 19.98% upside to its $26.00 target. While these figures indicate strong positive sentiment from sell-side analysts, the analysis itself carries a cautious undertone, prompting investors to question the validity of these targets and consider the possibility of them being relics of past optimism that could face future downgrades.

Key Decisions for Investors

• Investors with a bullish view on small-cap value could consider VIOV for diversified exposure, as it presents a potential 11.80% upside based on aggregated analyst consensus.
• For those seeking higher alpha, the specific holdings Minerals Technologies (MTX), Sun Country Airlines (SNCY), and Edgewell Personal Care (EPC) warrant further due diligence, given their individual analyst-projected upsides range from approximately 20% to 30%.
• It is crucial to scrutinize the assumptions behind the high price targets for the underlying stocks, as the analysis highlights the risk of analyst over-optimism and the potential for future target price downgrades.